In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
Cometta
A
A
Infectious Diseases Service, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Alain.cometta@ehnv.ch
Marchetti
O
O
Calandra
T
T
Bille
J
J
Kern
W V
WV
Zinner
S
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001372:Aza Compounds / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D009369:Neoplasms / Q000097:blood / Q000382:microbiology*; D009503:Neutropenia / Q000209:etiology; D011804:Quinolines / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin